OwlyTimes

#cost-savings

2 articles with this tag

Biosimilar Stalemate: Why Lower Drug Costs Aren't ArrivingHealth

Biosimilar Stalemate: Why Lower Drug Costs Aren't Arriving

Unlocking the biosimilar puzzle: Discover why lower drug costs haven't materialized. Our analysis exposes the hidden forces stalling competition & impactin...

Sustainability's Shift: $14B Shows Savings Now Drive Green SalesBusiness

Sustainability's Shift: $14B Shows Savings Now Drive Green Sales

Forget lofty ideals. Discover how $14B in sales proves sustainability’s future hinges on *savings*, not just ethics. We analyze the pragmatic shift reshapi...